22:00 , Mar 22, 2018 |  BC Innovations  |  Strategy

Janssen’s virtual discovery

In the latest example of how AI can accelerate drug discovery, Janssen has shown it can use machine learning to create virtual drug screens that outperform conventional assays. The most promising application may be in...
00:39 , Feb 1, 2018 |  BC Innovations  |  Emerging Company Profile

Non-adherence policy

Having worked out how to make non-adherent primary cells amenable to microscopy, Allcyte GmbH has created a platform for imaging interactions between T cells and B cells that can predict drug responses in hematological cancers....
19:27 , Oct 20, 2017 |  BC Week In Review  |  Company News

Allcyte and Boehringer to characterize cancer compounds

Last month, Allcyte said it partnered with Boehringer Ingelheim GmbH (Ingelheim, Germany) to use Allcyte's Pharmacoscopy...
20:31 , May 23, 2017 |  BC Innovations  |  Distillery Techniques

Assays and screens; imaging

TECHNOLOGY: Cellular assays; fluorescence An automated fluorescence microscopy method for detecting cell-cell interactions in human peripheral blood mononuclear cells (PBMCs) could be used to screen for immunomodulatory compounds. The method involved automated spinning disc confocal...